Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ENPH
|
Mandy Yang
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 12,117 Reduced 15.21% |
$1,972,769
$162.81 p/Share
|
Mar 02
2022 |
|
ENPH
|
David A Ranhoff
EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 15,376 Reduced 15.25% |
$2,503,367
$162.81 p/Share
|
Mar 02
2022 |
|
ENPH
|
Jeff Mc Neil
EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 20,784 Reduced 23.78% |
$3,383,843
$162.81 p/Share
|
Mar 02
2022 |
|
BANR
|
Brent A Orrico
Director |
BUY
Small Acquisition
|
Direct | 137 Added 0.37% |
$8,484
$61.93 p/Share
|
Mar 02
2022 |
|
BANR
|
Gary W Wagers
Executive VP, Banner Bank |
BUY
Small Acquisition
|
Direct | 7 Added 0.03% |
$434
$61.93 p/Share
|
Mar 02
2022 |
|
BANR
|
John R Layman
Director |
BUY
Small Acquisition
|
Direct | 47 Added 0.18% |
$2,911
$61.93 p/Share
|
Mar 02
2022 |
|
BANR
|
David A Klaue
Director |
BUY
Small Acquisition
|
Direct | 124 Added 0.11% |
$7,679
$61.93 p/Share
|
Mar 02
2022 |
|
KHC
|
Carlos Abrams Rivera
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 89,253 Reduced 17.2% |
$3,487,115
$39.07 p/Share
|
Mar 02
2022 |
|
AMC
|
Sean D. Goodman
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 107,412 Reduced 96.05% |
$1,945,231
$18.11 p/Share
|
Mar 02
2022 |
|
TRT
|
Richard M Horowitz |
BUY
Exercise of conversion of derivative security
|
Direct | 12,500 Added 3.4% |
$51,750
$4.14 p/Share
|
Mar 02
2022 |
|
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 1,203 Added 0.02% |
$3,850
$3.2 p/Share
|
Mar 02
2022 |
|
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 1,203 Added 0.02% |
$3,850
$3.2 p/Share
|
Mar 02
2022 |
|
LVO
|
Robert S Ellin
CEO & Chairman |
BUY
Open market or private purchase
|
Direct | 25,000 Added 1.34% |
$21,250
$0.85 p/Share
|
Mar 02
2022 |
|
NRDY
|
Charles K. Cohn
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 221,408 Added 50.0% |
$1,000,764
$4.52 p/Share
|
Mar 02
2022 |
|
ISTR
|
Jeffrey Wayne Martin
Chief Credit Officer |
BUY
Open market or private purchase
|
Direct | 1,714 Added 29.58% |
$34,983
$20.41 p/Share
|
Mar 02
2022 |
|
CIVB
|
Todd A Michel
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,115 Added 16.51% |
-
|
Mar 02
2022 |
|
CIVB
|
Lance A. Morrison
SVP, Legal Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 1,262 Added 26.88% |
-
|
Mar 02
2022 |
|
CIVB
|
Charles A. Parcher
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 2,225 Added 15.74% |
-
|
Mar 02
2022 |
|
CIVB
|
Dennis G Shaffer
CEO and President |
BUY
Grant, award, or other acquisition
|
Direct | 3,853 Added 13.81% |
-
|
Mar 02
2022 |
|
CIVB
|
Paul J Stark
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,259 Added 15.44% |
-
|
Mar 02
2022 |
|
CIVB
|
Donna M. Waltz Jaskolski
Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 966 Added 24.33% |
-
|
Mar 02
2022 |
|
RM
|
Michael R Dunn |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 11.14% |
$599,280
$49.94 p/Share
|
Mar 02
2022 |
|
DHIL
|
Paula R Meyer
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 21.02% |
$98,500
$197.0 p/Share
|
Mar 02
2022 |
|
AVA
|
Bryan Alden Cox
Senior Vice President |
SELL
Open market or private sale
|
Direct | 450 Reduced 8.8% |
$20,075
$44.61 p/Share
|
Mar 02
2022 |
|
CYTK
|
Santo J Costa
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 66.67% |
$373,500
$37.35 p/Share
|
Mar 02
2022 |
|
CYTK
|
Santo J Costa
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 40.0% |
$106,800
$10.68 p/Share
|
Mar 02
2022 |
|
WTS
|
Elie Melhem
President- APAC, M. East, Afr. |
SELL
Open market or private sale
|
Direct | 5,600 Reduced 30.14% |
$812,224
$145.04 p/Share
|
Mar 02
2022 |
|
W
|
Anke Schaferkordt
Director |
SELL
Open market or private sale
|
Direct | 11 Reduced 0.36% |
$1,444
$131.24 p/Share
|
Mar 02
2022 |
|
NXST
|
Charles Thomas Mc Millen |
SELL
Open market or private sale
|
Direct | 500 Reduced 12.9% |
$95,000
$190.0 p/Share
|
Mar 02
2022 |
|
AMC
|
Anthony J Saich
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,950 Added 20.09% |
-
|
Mar 02
2022 |
|
AMC
|
Kathleen M Pawlus
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,950 Added 20.09% |
-
|
Mar 02
2022 |
|
AMC
|
Howard Winchel Koch Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,950 Added 20.09% |
-
|
Mar 02
2022 |
|
AMC
|
Philip Lader
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,950 Added 20.09% |
-
|
Mar 02
2022 |
|
AMC
|
Adam Jay Sussman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,950 Added 20.09% |
-
|
Mar 02
2022 |
|
AMC
|
Gary Locke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,950 Added 20.09% |
-
|
Mar 02
2022 |
|
MIDD
|
John R Miller Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 845 Added 5.07% |
-
|
Mar 02
2022 |
|
MIDD
|
Gordon Obrien
Director |
BUY
Grant, award, or other acquisition
|
Direct | 845 Added 6.08% |
-
|
Mar 02
2022 |
|
MIDD
|
Nassem Ziyad
Director |
BUY
Grant, award, or other acquisition
|
Direct | 845 Added 8.75% |
-
|
Mar 02
2022 |
|
MIDD
|
Robert A Nerbonne
Director |
BUY
Grant, award, or other acquisition
|
Direct | 845 Added 22.38% |
-
|
Mar 02
2022 |
|
MIDD
|
Cathy L Mc Carthy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 845 Added 9.12% |
-
|
Mar 02
2022 |
|
MIDD
|
Chapin Sarah Palisi
Director |
BUY
Grant, award, or other acquisition
|
Direct | 845 Added 9.88% |
-
|
Mar 02
2022 |
|
DTE
|
Joi M. Harris
President & COO |
SELL
Open market or private sale
|
Direct | 1,650 Reduced 14.4% |
$199,601
$120.97 p/Share
|
Mar 02
2022 |
|
ADBE
|
Mark S. Garfield
SVP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 234 Reduced 13.08% |
$110,256
$471.18 p/Share
|
Mar 02
2022 |
|
ADBE
|
Mark S. Garfield
SVP & CAO |
BUY
Exercise of conversion of derivative security
|
Direct | 473 Added 20.91% |
-
|
Mar 02
2022 |
|
ABBV
|
Carrie C Strom
SVP & PRES GLOBAL ALLERG AESTH |
SELL
Payment of exercise price or tax liability
|
Direct | 810 Reduced 1.78% |
$119,629
$147.69 p/Share
|
Mar 02
2022 |
|
FRAF
|
Gregory A Duffey
Director |
BUY
Open market or private purchase
|
Direct | 30 Added 0.34% |
$1,007
$33.56 p/Share
|
Mar 02
2022 |
|
FRAF
|
Karen K Carmack
SVP, Chief HR Officer |
BUY
Open market or private purchase
|
Direct | 1 Added 0.04% |
$34
$33.56 p/Share
|
Mar 02
2022 |
|
FRAF
|
Patricia A Hanks
SVP |
BUY
Open market or private purchase
|
Direct | 3 Added 0.06% |
$101
$33.56 p/Share
|
Mar 02
2022 |
|
FRAF
|
Mark R Hollar
EVP/CFO |
BUY
Open market or private purchase
|
Direct | 3 Added 0.04% |
$101
$33.56 p/Share
|
Mar 02
2022 |
|
BLBD
|
Paul Yousif
General Counsel & Treasurer |
SELL
Open market or private sale
|
Direct | 3,720 Reduced 10.9% |
$77,190
$20.75 p/Share
|
Mar 02
2022 |